Choose Mounjaro for Appropriate Adult Patients with T2D
Avanzare Italian Dining
3240 S. Fremont Avenue
Springfield, MO 65804
Tuesday, August 12, 2025 at 5:30pm CT - 7:00pm CT
Add this event to your calendar
Info
Topic
Mounjaro
Additional Information
Engage directly with a highly-regarded peer about how once-weekly Mounjaro® (tirzepatide) may help your adult patients with type 2 diabetes (T2D) achieve their glycemic goals.
In this program, you will learn about:
- Mounjaro—the first and only glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic control in adults with type 2 diabetes1
- The clinical efficacy and safety of Mounjaro
How to get patients started on treatment
Speakers
Ralph Duda
MD
Primary Clinical Investigator-CardioMetabolic Studies at Clinvest Research